These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 8474062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC.
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [Abstract] [Full Text] [Related]

  • 3. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S, Lafforgue P, Blanc A, Catalin J, Aquaviva PC, Durand A.
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [Abstract] [Full Text] [Related]

  • 4. Folic acid alters methotrexate availability in patients with rheumatoid arthritis.
    Bressolle F, Kinowski JM, Morel J, Pouly B, Sany J, Combe B.
    J Rheumatol; 2000 Sep; 27(9):2110-4. PubMed ID: 10990220
    [Abstract] [Full Text] [Related]

  • 5. Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients.
    Bressolle F, Bologna C, Kinowski JM, Arcos B, Sany J, Combe B.
    J Rheumatol; 1997 Oct; 24(10):1903-9. PubMed ID: 9330930
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM, Petrillo GF, Hamilton RA.
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M, Booth J, Loxton A, McCarthy P, Meffin P, Kevat S.
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 19. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML.
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis.
    Dupuis LL, Koren G, Shore A, Silverman ED, Laxer RM.
    J Rheumatol; 1990 Nov; 17(11):1469-73. PubMed ID: 2273487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.